Skip to content
Their Record

Senate Roll Call 246, 108th Congress · June 25, 2003

To study the comparative effectiveness and safety of important Medicare covered drugs to ensure that consumers can make meaningful comparisons about the quality and efficacy.

Question before the chamber: On the Amendment

43 yea · 52 nayAmendment Rejected5 not voting or present
Democrat43 yea · 4 nay
Republican0 yea · 47 nay
Independent0 yea · 1 nay

Solid = yea, faded = nay.

The measure

S. 1 ↗

Prescription Drug and Medicare Improvement Act of 2003

Policy area: Health — assigned by Library of Congress subject specialists, not by this site.

How this vote is scored

Which tracked issues this roll call counts toward, and which way a yea vote moves a member on each. Direction is decided per issue, because one bill can push two issues opposite ways.

  • Health CareDirection unreadable — not scored

    excluded:model-unclear (0.80) Studying comparative drug effectiveness is an informational evaluation, not direct coverage expansion or restriction.

    Tagged by: policy-area:Health

    Axis: Expand coverage ← → Restrict coverage

Who voted which way

Every member recorded on this roll call, with the party they sat with at the time.

Yea (43)

Nay (52)

Not voting or present (5)

Vote records come from Voteview (voteview.com); bill titles and policy areas from the congress.gov API. See methodology for how the record was built.